Clinical Trials Browser

OTHER × Interventional × L19-IL2 immunocytokine × Clear all

NCT03705403 2025-01-30

IMMUNOSABR2

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02086721 2017-05-31

L19-IL2

Phase 1 Completed

Other solid neoplasm

Solid Tumour

NCT02735850 2017-05-23

ImmunoSABR

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung